Displaying 1241 - 1260 of 1549
Â鶹´«Ã½ Trade Commission Settles Price-Fixing Charges Against Washington University Physician Network
FTC Charges San Francisco's Brown & Toland Medical Group with Price-Fixing
Carlsbad Physician Association, Inc.; and William J. Baggs, M.D.; Srichand S. Dara, M.D.; Glen Moore; James J. Purpura, D.O.; Deborah J. Schenck, M.D.; Charles L. Secora, M.D.; Majid A. Syed, M.D.; and Richard L. Zizza, M.D
A New Mexico physician organization settled charges that it and its members entered into agreements to fix prices and to refuse to deal with third party payers and other health care plans except on collectively agreed-upon terms.
FTC/DOJ Hearings on Health Care And Competition Law and Policy
FTC Testifies on Consumer Access to Generic Pharmaceuticals
Texas Physicians' Group Agrees To Settle FTC Charges of Collective Bargaining
FTC/DOJ Hearings on Health Care And Competition Law and Policy
FTC/DOJ Hearings on Health Care and Competition Law and Policy
Two San Diego County Anesthesiology Groups Agree to Settle FTC Charges of Fixing Prices
Pfizer Inc. and Pharmacia Corporation
A final consent order permits Pfizer Inc.'s acquisition of Phamacia Corporation while requiring the divestiture of various products including extended release drugs used in the treatment of an overactive bladder; hormone replacement therapies; erectile dysfunction; canine arthritis; and motion sickness. Novartis AG, Neurocrine Biosciences, Inc., Schering-Plough Corporation, Johnson & Johnson, Insight Pharmaceuticals Corporation, and Cadbury Schweppes are named in the order as potential buyers of the various pharmaceuticals and products.
Special Challenges for Antitrust in Health Care
FTC/DOJ Hearings on Health Care and Competition Law and Policy
FTC/DOJ Hearings on Health Care and Competition Law and Policy
Fourth Session of FTC/DOJ Health Care and Competition Law and Policy Hearings to Be Held April 23-25
Pfizer, Pharmacia Will Divest Assets to Settle FTC Charges
FTC/DOJ Hearings on Health Care And Competition Law and Policy
Third Session of FTC/DOJ Health Care and Competition Law and Policy Hearings Begins Wednesday, April 9
Quest Diagnostics Inc.orporated and Unilab Corporation
Quest Diagnostics settled FTC charges that its proposed acquisition of Unilab Corporation would substantially increase concentration in the clinical laboratory testing services market by agreeing to divest clinical laboratory testing assets in Northern California to Laboratory Corporation of America.
Displaying 1241 - 1260 of 1549